Alaunos Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$4.50 | -$4.50 | -$4.50 |
| Q2 2024 | 1 | -$4.50 | -$4.50 | -$4.50 |
| Q3 2024 | 1 | -$4.50 | -$4.50 | -$4.50 |
| Q1 2025 | 1 | -$6.44 | -$6.44 | -$6.44 |
| Q2 2025 | 1 | -$5.33 | -$5.33 | -$5.33 |
| Q3 2025 | 1 | -$4.90 | -$4.90 | -$4.90 |
| Q4 2025 | 1 | -$3.69 | -$3.69 | -$3.69 |
Alaunos Therapeutics, Inc. Earnings Date And Information
Alaunos Therapeutics, Inc. last posted its earnings results on Tuesday, March 26th, 2024. The company reported $-0.6 earnings per share for the quarter, missing analysts' consensus estimates of $-0.6 by $0. The company had revenue of 0 for the quarter and had revenue of 5,000 for the year. Alaunos Therapeutics, Inc. has generated $-22 earnings per share over the last year ($-21.97 diluted earnings per share) and currently has a price-to-earnings ratio of -0.29. Alaunos Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Alaunos Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.70 | $0 | $0 | ||
| 08/14/2024 | Q2 2024 | -$0.71 | $4,000 | $4,000 | ||
| 05/15/2024 | Q1 2024 | -$1.05 | $1,000 | |||
| 04/01/2024 | Q4 2023 | -$4.90 | $1,000 | |||
| 09/29/2023 | Q3 2023 | -$5.30 | $0 | |||
| 08/14/2023 | Q2 2023 | -$6.00 | -$5.49 | 0.51 | $4,000 | |
| 05/10/2023 | Q1 2023 | -$6.00 | -$5.85 | 0.15 | $0 | |
| 03/07/2023 | Q4 2022 | -$13.49 | -$6.58 | 6.91 | $11,000 | |
| 11/14/2022 | Q3 2022 | -$17.99 | -$6.58 | 11.41 | $2.91 M | |
| 08/15/2022 | Q2 2022 | -$16.49 | -$6.84 | 9.65 | $0 | |
| 05/16/2022 | Q1 2022 | -$13.49 | -$7.32 | 6.17 | $0 | |
| 03/30/2022 | Q4 2021 | -$13.49 | -$8.24 | 5.25 | $0 | |
| 11/08/2021 | Q3 2021 | -$0.13 | -$15.89 | -15.76 | $398,000 | |
| 08/13/2021 | Q2 2021 | -$0.12 | -$15.86 | -15.74 | $0 | |
| 05/06/2021 | Q1 2021 | -$0.10 | -$15.11 | -15.01 | $0 | |
| 03/01/2021 | Q4 2020 | -$16.03 | $0 | |||
| 11/05/2020 | Q3 2020 | -$0.09 | -$14.32 | -14.23 | $0 | |
| 08/06/2020 | Q2 2020 | -$0.09 | -$13.11 | -13.02 | $0 | |
| 05/07/2020 | Q1 2020 | -$0.08 | -$13.73 | -13.65 | $0 | |
| 03/02/2020 | Q4 2019 | -$0.08 | -$13.16 | -13.08 | $0 |
Alaunos Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Alaunos Therapeutics, Inc.'s earnings date?
Alaunos Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
How can I listen to Alaunos Therapeutics, Inc.'s earnings conference call?
The conference call for Alaunos Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Alaunos Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Alaunos Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Alaunos Therapeutics, Inc. generate each year?
Alaunos Therapeutics, Inc. (:TCRT) has a recorded annual revenue of $5,000.
-
How much profit does Alaunos Therapeutics, Inc. generate each year?
Alaunos Therapeutics, Inc. (:TCRT) has a recorded net income of $5,000. Alaunos Therapeutics, Inc. has generated $-21.97 earnings per share over the last four quarters.
-
What is Alaunos Therapeutics, Inc.'s price-to-earnings ratio?
Alaunos Therapeutics, Inc. (:TCRT) has a price-to-earnings ratio of -0.29 and price/earnings-to-growth ratio is -0.01.
